mail
versión imprimible
 
 

3rd In Vivo Cell Engineering and Gene Editing Summit

Evvnt Promotion / evvnt
-
09.07.2024 - 11.07.2024  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:10 PM
 
Temas de la conferencia
Welcome to the 3rd In Vivo Cell Engineering and Gene Editing Summit!

As promising pre-clinical and proof of concept results continue to emerge, the pivotal shift from the 'dream' of in vivo cell engineering and gene editing is rapidly becoming a reality as numerous companies push towards the clinic.
Organizador profesional (PCO)
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2291382-3?pid=4832

Speakers: Adrian Bot, Chief Scientific Officer, Capstan Therapeutics, Cecile Bauche, Chief Scientific Officer, Alaya.bio, Colin Exline, Head of Gene Editing, Primera Therapeutics, and more
 

Información e inscripción:

https://go.evvnt.com/2291382-2?pid=4832
Ms. Kelly Cassidy
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Charité International AcademyAGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Public Health Association (EUPHA)Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHilfswerk AustriaSwiss Tropical and Public Health InstituteÄrztekammer für WienHelix - Forschung & Beratung Wien